What is the assessment and management plan for a 76‑year‑old male with prior cholecystectomy, hypertension, renal‑artery stenosis, chronic obstructive pulmonary disease (COPD), coronary artery bypass graft (CABG) on clopidogrel (Plavix), and migraine prophylaxis with valproic acid (Depakote) presenting with several days of left lower‑quadrant abdominal pain, nausea, vomiting, jaundice, leukocytosis, markedly elevated bilirubin, cholestatic liver enzyme elevation, and CT showing intra‑ and extra‑hepatic biliary dilatation with distal common bile duct stones (choledocholithiasis) and acute kidney injury?

Assessment and Plan: Choledocholithiasis with Biliary Obstruction and Acute Cholangitis

Assessment

This 76-year-old male presents with acute cholangitis secondary to distal common bile duct stones causing severe biliary obstruction, complicated by acute kidney injury and requiring urgent biliary decompression. 1

Primary Diagnosis: Acute Cholangitis with Choledocholithiasis

• Jaundice with markedly elevated total bilirubin (8.2 mg/dL) and direct bilirubin (4.8 mg/dL) indicates complete or near-complete biliary obstruction from the distal CBD stone cluster. 2
• Leukocytosis (16.2) with fever and abdominal pain constitutes Charcot's triad, confirming acute cholangitis requiring urgent intervention. 3
• Cholestatic pattern (alkaline phosphatase 156, AST 202, ALT 111) with severe biliary dilatation (common hepatic duct 18 mm, normal ≤10 mm post-cholecystectomy) confirms high-grade obstruction. 1
• Normal lipase (24) effectively excludes acute pancreatitis despite the mildly dilated pancreatic duct (6 mm). 2

Critical Complication: Acute Kidney Injury

• Creatinine elevation from baseline 0.87 to 1.82 mg/dL represents acute kidney injury, likely from sepsis-induced acute tubular necrosis in the setting of cholangitis. 3
• This AKI significantly increases perioperative mortality risk and mandates aggressive fluid resuscitation and urgent source control. 3

High-Risk Surgical Profile

• Recent CABG on clopidogrel creates bleeding risk, though laparoscopic cholecystectomy studies show no increased blood loss when clopidogrel is continued (mean 50 mL vs 47 mL, P=NS). 4
• Renal artery stenosis with baseline renal impairment increases risk of contrast-induced nephropathy and perioperative renal deterioration. 5
• COPD and cardiovascular disease elevate anesthesia risk substantially. 6

---

Management Plan

1. Immediate Resuscitation and Stabilization (Within 1 Hour)

Antibiotic Therapy

• Start broad-spectrum antibiotics within 1 hour using piperacillin-tazobactam 3.375 g IV every 6 hours (renally adjusted), imipenem-cilastatin, or meropenem for biliary sepsis. 2, 3
• Given prior cholecystectomy and current biliary infection, use fourth-generation cephalosporins with adjustments per antibiogram when cultures return. 2
• Continue antibiotics for 5-7 days total duration. 3

Fluid Resuscitation

• Administer aggressive IV crystalloid resuscitation targeting urine output >0.5 mL/kg/hr to reverse acute kidney injury and improve renal perfusion before any contrast exposure. 3
• Monitor lactate, which is currently normal, along with CRP and procalcitonin to assess sepsis severity and treatment response. 2, 3

Clopidogrel Management

• Continue clopidogrel through the perioperative period—discontinuation poses significant stent thrombosis risk (mortality up to 45% if stopped early post-CABG), while continuation does not increase bleeding in biliary procedures. 4
• If ERCP bleeding occurs despite continued clopidogrel, it is typically controllable without major sequelae. 7

---

2. Urgent Biliary Decompression (Within 24 Hours)

ERCP with Sphincterotomy and Stone Extraction

• Perform urgent ERCP within 24 hours as the treatment of choice for retained/obstructed bile duct stones, with high success rates for stone extraction. 1, 8
• Biliary sphincterotomy with stone extraction will decompress the biliary tree and provide source control for cholangitis. 3
• Place a biliary stent if complete stone clearance cannot be achieved in the first session to maintain drainage. 2, 3

Contrast Precautions

• Pre-hydrate aggressively with IV normal saline before and after ERCP to minimize contrast-induced nephropathy risk in this patient with baseline renal artery stenosis and acute kidney injury. 5
• Consider N-acetylcysteine 600 mg PO twice daily on the day before and day of procedure as additional nephroprotection. 5

Alternative if ERCP Fails

• If ERCP is technically unsuccessful or the patient is too unstable, proceed to percutaneous transhepatic biliary drainage (PTBD), which achieves approximately 90% technical success and 70-80% short-term clinical success for septic patients with complete CBD obstruction. 1

---

3. Monitoring and Supportive Care

Renal Function Monitoring

• Check creatinine and electrolytes every 12-24 hours until downtrending; target return to baseline 0.87 mg/dL. 3
• Maintain strict intake/output monitoring and adjust all medications for renal function. 2

Inflammatory Marker Trending

• Serial CRP, procalcitonin, and lactate measurements predict sepsis severity and mortality risk; trending values guide antibiotic duration and assess treatment response. 2, 3

Cardiovascular Monitoring

• Continuous telemetry given CABG history, especially with clopidogrel continuation and potential for perioperative stress. 6
• Optimize COPD management with bronchodilators and avoid oversedation during procedures. 6

---

4. Definitive Management After Stabilization

Post-ERCP Assessment

• Repeat liver function tests 24-48 hours post-ERCP to confirm downtrending bilirubin and alkaline phosphatase, indicating successful decompression. 2
• If bilirubin fails to decrease or rises further, obtain urgent contrast-enhanced MRCP to evaluate for residual stones, bile leak, or iatrogenic injury. 1

Long-term Biliary Management

• This patient has already undergone cholecystectomy, so no further surgical intervention is needed unless ERCP reveals a bile duct stricture or injury. 8
• If a stricture is identified, endoscopic management with multiple plastic stents exchanged every 4-8 weeks achieves 74-90% success rates. 1

---

5. Critical Pitfalls to Avoid

• Never delay ERCP beyond 24 hours in acute cholangitis—mortality increases significantly with delayed biliary decompression, and unrecognized obstruction can progress to secondary biliary cirrhosis and liver failure. 1, 3
• Do not discontinue clopidogrel for ERCP—stent thrombosis risk far exceeds bleeding risk, and studies show no increased blood loss in biliary procedures when clopidogrel is continued. 4, 7
• Do not rely on normal lipase to exclude biliary pathology—this patient's cholangitis is confirmed by imaging and labs despite normal pancreatic enzymes. 2
• Do not administer contrast for MRCP or CT before aggressive hydration in this patient with renal artery stenosis and AKI—contrast-induced nephropathy could precipitate dialysis requirement. 5
• Never dismiss the acute kidney injury as "pre-renal"—this represents sepsis-induced organ dysfunction requiring urgent source control via biliary decompression. 3

---

6. Disposition

• Admit to intensive care unit or step-down unit for close hemodynamic monitoring, given sepsis with organ dysfunction (AKI) and high-risk comorbidities. 3
• Coordinate urgent ERCP with gastroenterology within 24 hours; delay beyond this window significantly increases morbidity and mortality. 1
• Consult nephrology if creatinine does not improve after biliary decompression and fluid resuscitation, as this may indicate acute tubular necrosis requiring renal replacement therapy. 3